Summary:
- The U.S. Supreme Court has stopped Purdue Pharma's $6 billion opioid settlement with the Sackler family.
- The Sacklers sought protection from opioid-related civil claims through the settlement.
- The intervention by the Supreme Court is drawing widespread attention.
- A hearing for this case is slated for December.
The U.S. Supreme Court has halted Purdue Pharma's bankruptcy proceedings, effectively putting a hold on a $6 billion opioid settlement involving the Sackler family, the former owners of the company.
The Sackler family, which controlled Purdue Pharma, had agreed to the $6 billion settlement as a means of obtaining comprehensive protection against civil claims linked to the opioid crisis. However, the Supreme Court's intervention has suspended the settlement's progression. This move has garnered significant attention due to its unprecedented nature, with even the Biden administration expressing concerns.
The Supreme Court has scheduled a hearing for this case in December, indicating that the final verdict on the Purdue Pharma settlement is still pending.